Incyte announces validation by EMA of its MAA for pemigatinib in patients with cholangiocarcinoma Read more
Schrödinger and Bayer Collaborate to Co-Develop de novo Design Technology to Accelerate Drug Discovery Read more
Immunic Exercises its Option for the Exclusive Worldwide License to IMU-856 from Daiichi Sankyo Read more
Catabasis and Duchenne Announce Partnership to Evaluate Edasalonexent in a Phase 2 Non-Ambulatory DMD Trial Read more
Candel Therapeutics Acquires Next-Generation Herpes Drug Development Platform and Manufacturing Expertise Read more
Galecto and PharmAkea merge to create strong clinical-stage company developing first-in-class therapeutics in fibrosis and cancer Read more